Pragmatic Factorial Cluster Trial of Framing and Comparators for Audit and Feedback
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT02979964 |
Recruitment Status :
Completed
First Posted : December 2, 2016
Last Update Posted : October 5, 2018
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Condition or disease | Intervention/treatment | Phase |
---|---|---|
High-risk Prescribing in Nursing Homes | Behavioral: Audit and Feedback | Not Applicable |
Study Type : | Interventional (Clinical Trial) |
Actual Enrollment : | 285 participants |
Allocation: | Randomized |
Intervention Model: | Factorial Assignment |
Masking: | Single (Outcomes Assessor) |
Primary Purpose: | Health Services Research |
Official Title: | Pragmatic Factorial Cluster Trial of Framing and Comparators for Audit and Feedback Aiming to Address High Risk Prescribing in Nursing Homes in Ontario |
Actual Study Start Date : | December 6, 2016 |
Actual Primary Completion Date : | October 6, 2017 |
Actual Study Completion Date : | July 2018 |

Arm | Intervention/treatment |
---|---|
Experimental: Arm 1, Positive Framing
All metrics in the audit and feedback practice reports presented with 'positive' framing, where the proportion of patients safe from risk (i.e., appropriate/desirable prescribing behaviours) is described.
|
Behavioral: Audit and Feedback |
Experimental: Arm 2, Negative Framing
All metrics in the audit and feedback practice reports presented with 'negative' framing, where the proportion of patients at risk (i.e., due to inappropriate/undesirable prescribing behaviours) is described.
|
Behavioral: Audit and Feedback |
Experimental: Arm 3, Top Quartile Comparator
All metrics in the audit and feedback practice reports presented and the physician-recipient's performance is compared against the 75th percentile for performance by physicians working in nursing homes in the province for each metric.
|
Behavioral: Audit and Feedback |
Experimental: Arm 4, Average Comparator
All metrics in the audit and feedback practice reports presented and the physician-recipient's performance is compared against the average performance by physicians working in nursing homes in the province for each metric.
|
Behavioral: Audit and Feedback |
- CNS-active medication prescribing [ Time Frame: 6 months ]monthly number of CNS-active medications per resident (antipsychotics, opioids, benzodiazepines or antidepressants (including TCAs and trazodone))
- Benzodiazepine (or z-drug) prescribing [ Time Frame: 6 months ]days supplied (continuous)
- Benzodiazepine (or z-drug) rates [ Time Frame: 6 months ]monthly proportion
- Antipsychotic rates [ Time Frame: 6 months ]monthly proportion
- Antipsychotic prescribing [ Time Frame: 6 months ]days supplied (continuous)
- Mean Antipsychotic dose [ Time Frame: 6 months ]Dose equivalent of antipsychotic dispensed (continuous)
- Mean Benzodiazepine dose [ Time Frame: 6 months ]Dose equivalent of benzodiazepine dispensed (continuous)
- 3+ CNS-active medications [ Time Frame: 6 months ]monthly proportion supplied three or more meds from the following classes: antipsychotics, opioids, benzodiazepines, or antidepressants (including TCAs and trazodone).
- Anti-depressant prescribing [ Time Frame: 6 months ]days supplied (continuous) - balance measure
- Anti-acid prescribing [ Time Frame: 6 months ]days supplied (continuous) - tracer outcome
- Statin prescribing [ Time Frame: 6 months ]days supplied (continuous) - tracer outcome

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | Child, Adult, Older Adult |
Sexes Eligible for Study: | All |
Accepts Healthy Volunteers: | Yes |
Inclusion Criteria:
- a physician licensed by the College of Physicians and Surgeons of Ontario (CPSO);
- practice in at least one LTC facility in Ontario;.
- have voluntarily signed up to receive an HQO practice report
Exclusion Criteria:
- n/a

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02979964
Canada, Ontario | |
Women's College Hospital | |
Toronto, Ontario, Canada, M5S1B2 |
Principal Investigator: | Noah M Ivers, MD PhD CCFP | Women's College Hospital - University of Toronto |
Publications:
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
Responsible Party: | Noah Ivers, M.D., PhD, CCFP, Women's College Hospital |
ClinicalTrials.gov Identifier: | NCT02979964 |
Other Study ID Numbers: |
2016-0122-E |
First Posted: | December 2, 2016 Key Record Dates |
Last Update Posted: | October 5, 2018 |
Last Verified: | October 2018 |
Individual Participant Data (IPD) Sharing Statement: | |
Plan to Share IPD: | No |
Plan Description: | Analyses of outcomes use routine administrative database holdings. |